Works by Zanwar, Saurabh
Results: 43
Ciltacabtagene Autoleucel for the Treatment of Relapsed/Refractory Multiple Myeloma: Efficacy, Safety, and Place in Therapy.
- Published in:
- Cancer Management & Research, 2025, v. 17, p. 357, doi. 10.2147/CMAR.S510408
- By:
- Publication type:
- Article
The immunome of mobilized peripheral blood stem cells is predictive of long-term outcomes and therapy-related myeloid neoplasms in patients with multiple myeloma undergoing autologous stem cell transplant.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00920-9
- By:
- Publication type:
- Article
Second symptomatic COVID-19 infections in patients with an underlying monoclonal gammopathy.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 11, p. 1, doi. 10.1038/s41408-022-00752-z
- By:
- Publication type:
- Article
Clinical and therapeutic implications of BRAF fusions in histiocytic disorders.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 6, p. 1, doi. 10.1038/s41408-022-00693-7
- By:
- Publication type:
- Article
The Effect of Duration of Lenalidomide Maintenance and Outcomes of Different Salvage Regimens in Patients with Multiple Myeloma (MM).
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 9, p. 1, doi. 10.1038/s41408-021-00548-7
- By:
- Publication type:
- Article
Immune-based therapies in the management of multiple myeloma.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 8, p. N.PAG, doi. 10.1038/s41408-020-00350-x
- By:
- Publication type:
- Article
MM-431: A Comparison Between Daratumumab and Non-Daratumumab-Based Salvage Regimens Used at First Relapse Post-Lenalidomide Maintenance in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S444, doi. 10.1016/S2152-2650(21)01987-X
- By:
- Publication type:
- Article
MM-429: Impact of Prolonged Lenalidomide Maintenance (≥3 years) and Outcomes in Patients with Multiple Myeloma Post-Autologous Stem Cell Transplant.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S443, doi. 10.1016/S2152-2650(21)01986-8
- By:
- Publication type:
- Article
IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S401, doi. 10.1016/S2152-2650(21)01906-6
- By:
- Publication type:
- Article
Poster: MM-431: A Comparison Between Daratumumab and Non-Daratumumab-Based Salvage Regimens Used at First Relapse Post-Lenalidomide Maintenance in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S256, doi. 10.1016/S2152-2650(21)01611-6
- By:
- Publication type:
- Article
Poster: MM-429: Impact of Prolonged Lenalidomide Maintenance (≥3 years) and Outcomes in Patients with Multiple Myeloma Post-Autologous Stem Cell Transplant.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S252, doi. 10.1016/S2152-2650(21)01580-9
- By:
- Publication type:
- Article
Poster: IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S244, doi. 10.1016/S2152-2650(21)01536-6
- By:
- Publication type:
- Article
Oral Abstract: IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S203, doi. 10.1016/S2152-2650(21)01277-5
- By:
- Publication type:
- Article
Progression risk stratification of Asymptomatic Waldenström Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e38, doi. 10.1016/j.clml.2019.09.058
- By:
- Publication type:
- Article
Antibiotic lock therapy for salvage of tunneled central venous catheters with catheter colonization and catheter‐related bloodstream infection.
- Published in:
- Transplant Infectious Disease, 2019, v. 21, n. 1, p. N.PAG, doi. 10.1111/tid.13017
- By:
- Publication type:
- Article
Treatment paradigm in Waldenström macroglobulinemia: frontline therapy and beyond.
- Published in:
- Therapeutic Advances in Hematology, 2022, v. 13, p. 1, doi. 10.1177/20406207221093962
- By:
- Publication type:
- Article
EGFR mutation in squamous cell carcinoma of the lung: does it carry the same connotation as in adenocarcinomas?
- Published in:
- OncoTargets & Therapy, 2017, v. 10, p. 1859, doi. 10.2147/OTT.S125397
- By:
- Publication type:
- Article
Risk‐adapted treatment in multiple myeloma: Does more make it merrier?
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 767, doi. 10.1111/bjh.19676
- By:
- Publication type:
- Article
Disease outcomes and biomarkers of progression in smouldering Waldenström macroglobulinaemia.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 2, p. 210, doi. 10.1111/bjh.17691
- By:
- Publication type:
- Article
Partial response or better at six months is prognostic of superior progression‐free survival in Waldenström macroglobulinaemia patients treated with ibrutinib.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 542, doi. 10.1111/bjh.17225
- By:
- Publication type:
- Article
Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomes.
- Published in:
- British Journal of Haematology, 2020, v. 188, n. 3, p. 394, doi. 10.1111/bjh.16168
- By:
- Publication type:
- Article
Impact of MYD88<sup>L265P</sup> mutation status on histological transformation of Waldenström Macroglobulinemia.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 3, p. 274, doi. 10.1002/ajh.25697
- By:
- Publication type:
- Article
Predictors of symptomatic hyperviscosity in Waldenström macroglobulinemia.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 11, p. 1384, doi. 10.1002/ajh.25254
- By:
- Publication type:
- Article
Clonal plasma cell proportion in the synthetic phase identifies a unique high-risk cohort in multiple myeloma.
- Published in:
- Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01232-w
- By:
- Publication type:
- Article
Chimeric antigen receptor T‐cell therapy in hematologic malignancies: Successes, challenges, and opportunities.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 2, p. 197, doi. 10.1111/ejh.14074
- By:
- Publication type:
- Article
Experience with non-cremophor-based paclitaxel-gemcitabine regimen in advanced pancreatic cancer: Results from a single tertiary cancer centre.
- Published in:
- Indian Journal of Medical Research, 2018, v. 148, n. 3, p. 284, doi. 10.4103/ijmr.IJMR_249_17
- By:
- Publication type:
- Article
Central nervous system involvement (Bing-Neel Syndrome) in patients with Waldenström macroglobulinemia.
- Published in:
- Leukemia & Lymphoma, 2023, v. 64, n. 8, p. 1490, doi. 10.1080/10428194.2023.2214026
- By:
- Publication type:
- Article
Disease heterogeneity, prognostication and the role of targeted therapy in multiple myeloma.
- Published in:
- Leukemia & Lymphoma, 2021, v. 62, n. 13, p. 3087, doi. 10.1080/10428194.2021.1957875
- By:
- Publication type:
- Article
Predictors of short-term survival in Waldenström Macroglobulinemia.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Prognostic significance of PD-L1 and TLR5 expression in peripheral T-cell lymphomas.
- Published in:
- Leukemia & Lymphoma, 2019, v. 60, n. 11, p. 2599, doi. 10.1080/10428194.2019.1608534
- By:
- Publication type:
- Article
Epidermal growth factor receptor mutated lung cancers: Looking beyond adenocarcinomas.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Efficacy of crizotinib in ALK mutant non-small cell lung cancers that are positive by IHC but negative by FISH compared to FISH positive cases.
- Published in:
- Indian Journal of Cancer, 2018, v. 55, n. 1, p. 678, doi. 10.4103/ijc.IJC_532_16
- By:
- Publication type:
- Article
Efficacy of crizotinib in ALK mutant non-small cell lung cancers that are positive by IHC but negative by FISH compared to FISH positive cases.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Neoadjuvant Chemotherapy in Locally Advanced and Borderline Resectable Nonsquamous Sinonasal Tumors (Esthesioneuroblastoma and Sinonasal Tumor with Neuroendocrine Differentiation).
- Published in:
- International Journal of Surgical Oncology, 2016, p. 1, doi. 10.1155/2016/6923730
- By:
- Publication type:
- Article
Autologous and Allogeneic Stem‐Cell Transplantation for Transformed Waldenström Macroglobulinemia.
- Published in:
- American Journal of Hematology, 2025, v. 100, n. 2, p. 338, doi. 10.1002/ajh.27543
- By:
- Publication type:
- Article
Clinical characteristics, molecular aberrations, treatments, and outcomes of malignant histiocytosis.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 5, p. 871, doi. 10.1002/ajh.27263
- By:
- Publication type:
- Article
Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myeloma.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1540, doi. 10.1002/ajh.27023
- By:
- Publication type:
- Article
Risk factors for severe infection and mortality In patients with COVID‐19 in patients with multiple myeloma and AL amyloidosis.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 1, p. 49, doi. 10.1002/ajh.26762
- By:
- Publication type:
- Article
Hiding in (not so) plain sight: Spontaneous tumor Lysis syndrome due to intravascular large B cell lymphoma.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 1, p. 151, doi. 10.1002/ajh.26383
- By:
- Publication type:
- Article
Assessment of fixed‐duration therapies for treatment‐naïve Waldenström macroglobulinemia.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 8, p. 945, doi. 10.1002/ajh.26210
- By:
- Publication type:
- Article
Monoclonal Gammopathy of Undetermined Significance: Current Concepts and Future Prospects.
- Published in:
- Current Hematologic Malignancy Reports, 2020, v. 15, n. 2, p. 45, doi. 10.1007/s11899-020-00569-2
- By:
- Publication type:
- Article
Novel Treatment Strategies in the Management of Waldenström Macroglobulinemia.
- Published in:
- Current Hematologic Malignancy Reports, 2020, v. 15, n. 1, p. 31, doi. 10.1007/s11899-020-00559-4
- By:
- Publication type:
- Article
Challenges and Strategies in the Management of Multiple Myeloma in the Elderly Population.
- Published in:
- Current Hematologic Malignancy Reports, 2019, v. 14, n. 2, p. 70, doi. 10.1007/s11899-019-00500-4
- By:
- Publication type:
- Article